000 | 03366cam a22005538i 4500 | ||
---|---|---|---|
001 | on1351659716 | ||
003 | OCoLC | ||
005 | 20241121073104.0 | ||
006 | m d | ||
007 | cr ||||||||||| | ||
008 | 221115s2022 nyu ob 001 0 eng | ||
010 | _a 2022054766 | ||
040 |
_aDLC _beng _erda _cDLC _dYDX _dOCLCO _dN$T |
||
020 |
_a8886974661 _q(electronic bk.) |
||
020 |
_a9788886974660 _q(electronic bk.) |
||
020 |
_a8886974663 _q(electronic bk.) |
||
020 |
_a9798886974669 _q(electronic bk.) |
||
020 |
_z9798886974089 _q(hardcover) |
||
035 |
_a3452120 _b(N$T) |
||
035 | _a(OCoLC)1351659716 | ||
042 | _apcc | ||
050 | 0 | 0 | _aQH599 |
082 | 0 | 0 |
_a572.8/7 _223/eng/20230118 |
049 | _aMAIN | ||
245 | 0 | 0 |
_aHMGB1 : _bfunctions, inhibitors and clinical significance / _cEylem Taskin, PhD (editor), Professor, Physiology, Adiyaman University, Adiyaman, Turkey, Celal Guven, PhD (editor), Associate Professor, Biophysics, Adiyaman University, Adiyaman, Turkey, Salih Tunc Kaya, PhD (editor), Assistant Dr., Biology, Duzce University, Duzce, Turkey. |
263 | _a2301 | ||
264 | 1 |
_aNew York : _bNova Science Publishers, _c[2022] |
|
300 | _a1 online resource. | ||
336 |
_atext _btxt _2rdacontent |
||
337 |
_acomputer _bc _2rdamedia |
||
338 |
_aonline resource _bcr _2rdacarrier |
||
490 | 0 | _aLife sciences research and development | |
504 | _aIncludes bibliographical references and index. | ||
520 |
_a"High mobility group box-1 (HMGB1) is one of the Damage-associated molecular patterns (DAMPs). HMGB1 plays plenty of role in both physiologic and pathophysiologic processes associated with its location, the receptor it binds to, and its redox form of its. Its functions are basically well known to have transcription factors, chemo-attractive effects, proinflammatory cytokine, neither chemokine nor cytokine effects, nor tissue repair function as well. This book provides an overview of the updated understanding of the dual role of HMGB1 in health and disease, such as cancer, myocardial ischemia/reperfusion injury, epilepsy, diabetes, multiple sclerosis, and neurodegenerative disease as well as hepatic steatosis and fatty liver disease been studied for years. That is why the modulation of HMGB1 might be a good candidate for the therapeutic of these diseases. Consequently, the present book comprises the role of HMGB1 in various pathologies and discusses its therapeutic potential in those pathologies"-- _cProvided by publisher. |
||
588 | _aDescription based on print version record and CIP data provided by publisher; resource not viewed. | ||
590 | _aAdded to collection customer.56279.3 | ||
650 | 0 |
_aChromatin _xMiscellanea. _921927 |
|
650 | 0 |
_aNervous system _xDiseases _xPathophysiology. _921928 |
|
650 | 6 |
_aChromatine _xMiscellan�ees. _921929 |
|
650 | 6 |
_aSyst�eme nerveux _xMaladies. _921930 |
|
700 | 1 |
_aTaskin, Eylem, _eeditor. _921931 |
|
700 | 1 |
_aGuven, Celal, _eeditor. _921932 |
|
700 | 1 |
_aKaya, Salih Tun�c, _eeditor. _921933 |
|
776 | 0 | 8 |
_iPrint version: _tHMGB1 _dNew York : Nova Science Publishers, [2022] _z9798886974089 _w(DLC) 2022054765 |
856 | 4 | 0 |
_3EBSCOhost _uhttps://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=3452120 |
938 |
_aYBP Library Services _bYANK _n303275094 |
||
938 |
_aEBSCOhost _bEBSC _n3452120 |
||
994 |
_a92 _bN$T |
||
999 |
_c8606 _d8606 |